A novel event-free survival endpoint in locally advanced pancreatic cancer

The treatment paradigm for locally advanced pancreatic cancer (LAPC) is evolving rapidly. The development of neoadjuvant therapies composed of combination therapies and the evaluation of their impact on conversion to borderline resectable (BR) status, resection, and ultimately overall survival (OS)...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Pascal Hammel, Ewa Carrier, Mairead Carney, Mark Eisner, Thomas Fleming
Format: article
Langue:EN
Publié: SAGE Publishing 2021
Sujets:
Accès en ligne:https://doaj.org/article/40c80974de284a6c9e33fe3074c7496e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!